|
|||||
|
|
Detection and treatment of minimal residual disease in high-risk neuroblastoma |
|
| Authors: | C. Patrick Reynolds |
| Affiliation: | Developmental Therapeutics Program, USC-CHLA Institute for Pediatric Clinical Research, Childrens Hospital Los Angeles and Division of Hematology-Oncology, Department of Pediatrics, The University of Southern California Keck School of Medicine, Los Angeles, CA, USA |
| Abstract: | |
| Keywords: | retinoids 13-cis-retinoic acid fenretinide blood or bone marrow purging MIBG |